
Adrenal oncocytoma: An incidental fluorodeoxyglucose positron emission tomography/computed tomography findings with magnetic resonance imaging correlation
Author(s) -
Khalid Alsugair,
Mamdoh Al Obaidy,
Mohammed Al Qahtani,
Amr Maged El Saadany,
Mohei Abouzied
Publication year - 2018
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/ijnm.ijnm_78_18
Subject(s) - medicine , magnetic resonance imaging , positron emission tomography , radiology , malignancy , fluorodeoxyglucose , differential diagnosis , tomography , biopsy , oncocytoma , nuclear medicine , pathology , renal cell carcinoma
A good percentage of adrenal masses in patients with known malignancy may be benign; thus, noninvasive characterization is important in preventing unnecessary biopsy. This case report represents a patient with papillary thyroid carcinoma and known lung metastasis for which she was followed up with whole-body fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) postradioactive iodine therapy. During the follow-up, she had developed an adrenal mass lesion seen by FDG PET/CT and further characterized by magnetic resonance imaging (MRI). This case demonstrates the potential importance of combining the molecular characterization by FDG PET/CT with the data derived from MRI in narrowing the differential diagnosis of an adrenal mass and suggesting the next diagnostic step in reaching the definitive diagnosis.